Zak Mir takes a technical analysis look at some of the most followed stocks on the London market. Today’s selection includes Blackbird, Braveheart, Eurasia, Ferro Alloy, Gunsynd, Minds, Prospex, Premier
Zak Mir takes a technical analysis look at some of the most followed stocks on the London market. Today’s selection includes Blackbird, Braveheart, Eurasia, Ferro Alloy, Gunsynd, Minds, Prospex, Premier
Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
Biotech group Tiziana Life Sciences (TILS), whose shares have finally rallied from below 50p to around 70p in recent days, in the run up to heading for pastures new in
London/New York, 3 September 2021 – Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) (“Old Tiziana”) a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases
Premier African Minerals (PREM) updated on progress at its Zulu Lithium and Tantalum project in Zimbabwe where drilling has commenced with 1,000 meters completed.
Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
Huge honour to be able to play a small part in today Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects
There was light emanating from what has been a rather long tunnel in terms of the milestones for Russia focused exploration and resource development company, Amur Minerals (AMC).
London/New York, August 20, 2021 – Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) (“Old Tiziana”) a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases
Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19
Huge honour to support Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects in the Balkans registration charity, please donating here & share.